{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:34:32Z","timestamp":1788928472359,"version":"build-2803163510"},"reference-count":42,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministry of Science and Higher Education, Warsaw, Poland","award":["2 P05D 095 30"],"award-info":[{"award-number":["2 P05D 095 30"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.ejphar.2013.02.054","type":"journal-article","created":{"date-parts":[[2013,3,13]],"date-time":"2013-03-13T17:40:39Z","timestamp":1363196439000},"page":"92-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Combined treatment with gabapentin and drugs affecting the renin\u2013angiotensin system against electroconvulsions in mice"],"prefix":"10.1016","volume":"706","author":[{"given":"Krzysztof","family":"\u0141ukawski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Janowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Jakubus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Raszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanis\u0142aw J.","family":"Czuczwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.02.054_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000134913","article-title":"Une nouvelle methode simple pour explorerl'action \u2018tranquilisante': le test de la cheminee","volume":"3","author":"Boissier","year":"1960","journal-title":"Med. Exp. (Basel)"},{"key":"10.1016\/j.ejphar.2013.02.054_bib2","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1046\/j.1528-1157.2002.34301.x","article-title":"Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis","volume":"43","author":"Borowicz","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib3","first-page":"803","article-title":"Evaluation of interaction between gabapentin and baclofen in the formalin test in mice","volume":"55","author":"Czuczwar","year":"2003","journal-title":"Pol. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib4","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00023210-200115050-00001","article-title":"The new generation of GABA enhancers","volume":"15","author":"Czuczwar","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ejphar.2013.02.054_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0920-1211(97)00031-4","article-title":"Comparison of the preclinical anticonvulsant profiles of tiagabine, lamotrigine, gabapentin and vigabatrin","volume":"28","author":"Dalby","year":"1997","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.02.054_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.phrs.2011.11.005","article-title":"Fosinopril and zofenopril, two angiotensin-converting enzyme (ACE) inhibitors, potentiate the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA\/2 mice","volume":"65","author":"De Sarro","year":"2012","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2013.02.054_bib7","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0022-3565(24)34865-7","article-title":"Transport of [3H]losartan across isolated perfused rabbit proximal tubule","volume":"290","author":"Edwards","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib8","doi-asserted-by":"crossref","first-page":"605","DOI":"10.2147\/VHRM.S23468","article-title":"Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk","volume":"7","author":"Farsang","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"10.1016\/j.ejphar.2013.02.054_bib9","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib10","doi-asserted-by":"crossref","first-page":"5768","DOI":"10.1074\/jbc.271.10.5768","article-title":"The novel anticonvulsant drug, gabapentin (neurontin), binds to the alpha2delta subunit of a calcium channel","volume":"271","author":"Gee","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2013.02.054_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0143-4179(96)90000-1","article-title":"Effects of non-peptide angiotensin II-receptor antagonists on pentylenetetrazol kindling in mice","volume":"30","author":"Georgiev","year":"1996","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2013.02.054_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S0022-3565(24)29352-6","article-title":"AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats","volume":"298","author":"Gohlke","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0920-1211(95)00028-9","article-title":"Effects of anticonvulsant drug gabapentin on the enzymes in metabolic pathways of glutamate and GABA","volume":"22","author":"Goldlust","year":"1995","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.02.054_bib14","first-page":"F56","article-title":"Interactions of organic anions with the organic cation transporter in renal BBMV","volume":"254","author":"Hsyu","year":"1988","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib15","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(95)92411-6","article-title":"Angiotensin receptor antagonists: focus on losartan","volume":"346","author":"Johnston","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2013.02.054_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0163-7258(01)00122-X","article-title":"The mechanisms of action of commonly used antiepileptic drugs","volume":"90","author":"Kwan","year":"2001","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib17","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2125.2010.03616.x","article-title":"Clinical pharmacokinetic drug interaction studies of gabapentin enacarbil, a novel transported prodrug of gabapentin, with naproxen and cimetidine","volume":"69","author":"Lal","year":"2010","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib18","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1734-1140(11)70497-2","article-title":"Basic mechanisms of antiepileptic drugs and their pharmacokinetic\/pharmacodynamic interactions: an update","volume":"63","author":"Laso\u0144","year":"2011","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejphar.2013.02.054_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0920-1211(91)90075-Q","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. II. Maximal electroshock seizure models","volume":"8","author":"L\u00f6scher","year":"1991","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.ejphar.2013.02.054_bib21","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00702-010-0455-y","article-title":"Captopril potentiates theanticonvulsant activity of carbamazepine and lamotrigine in the mouse maximal electroshock seizure model","volume":"117","author":"\u0141ukawski","year":"2010","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.ejphar.2013.02.054_bib22","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejphar.2010.04.053","article-title":"Angiotensin AT1 receptor antagonists enhance the anticonvulsant action of valproate in the mouse model of maximal electroshock","volume":"640","author":"\u0141ukawski","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pbb.2011.06.030","article-title":"Interactions between ACE inhibitors and classical antiepileptic drugs in the mouse maximal electroshock seizures","volume":"100","author":"\u0141ukawski","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejphar.2013.02.054_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00210-004-0867-z","article-title":"Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study","volume":"369","author":"\u0141uszczki","year":"2004","journal-title":"Naunyn-Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib25","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1046\/j.1528-1157.2003.32702.x","article-title":"Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis","volume":"44","author":"\u0141uszczki","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib26","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/sj.npp.1300243","article-title":"Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice","volume":"28","author":"\u0141uszczki","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"Suppl 6","key":"10.1016\/j.ejphar.2013.02.054_bib27","first-page":"S39","article-title":"Gabapentin in the management of convulsive disorders","volume":"40","author":"McLean","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib28","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1472-8206.1987.tb00547.x","article-title":"Effect of peptidyl-dipeptidase inhibitors in experimental convulsions in mice","volume":"1","author":"Minano","year":"1987","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib29","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib30","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1474-4422(03)00409-5","article-title":"Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs","volume":"2","author":"Patsalos","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.ejphar.2013.02.054_bib31","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1152\/physrev.00036.2005","article-title":"Physiology of local renin\u2013angiotensin systems","volume":"86","author":"Paul","year":"2006","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ejphar.2013.02.054_bib32","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1042\/CS20100053","article-title":"Inhibition of the renin\u2013angiotensin system prevents seizures in a rat model of epilepsy","volume":"119","author":"Pereira","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"issue":"Suppl. 9","key":"10.1016\/j.ejphar.2013.02.054_bib33","first-page":"S7","article-title":"The clinical pharmacokinetics of the new antiepileptic drugs","volume":"40","author":"Perucca","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2013.02.054_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0090-9556(25)06578-X","article-title":"Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys","volume":"23","author":"Radulovic","year":"1995","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejphar.2013.02.054_bib35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0143-4179(98)90065-8","article-title":"Involvement of cholinergic system in losartan-induced facilitation of spatial and short-term working memory","volume":"32","author":"Raghavendra","year":"1998","journal-title":"Neuropeptides"},{"key":"10.1016\/j.ejphar.2013.02.054_bib36","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.seizure.2010.05.008","article-title":"Antiepileptic treatment in patients with epilepsy and other comorbidities","volume":"19","author":"Ruiz-Gim\u00e9nez","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.ejphar.2013.02.054_bib37","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.lfs.2004.10.012","article-title":"Angiotensin peptides modulatory system: how is it implicated in the control of seizure susceptibility?","volume":"76","author":"Tchekalarova","year":"2005","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2013.02.054_bib38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01857634","article-title":"Angiotensin converting enzyme inhibitors: comparative structure, pharmacokinetics, and pharmacodynamics","volume":"4","author":"Thind","year":"1990","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib39","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.clpt.6100271","article-title":"Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin","volume":"83","author":"Urban","year":"2008","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.ejphar.2013.02.054_bib40","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/321864a0","article-title":"Benzodiazepine impairs and \u03b2-carboline enhances performance in learning and memory tasks","volume":"321","author":"Venault","year":"1986","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2013.02.054_bib41","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00441-006-0190-8","article-title":"The CNS renin\u2013angiotensin system","volume":"326","author":"von Bohlen und Halbach","year":"2006","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.ejphar.2013.02.054_bib42","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pneurobio.2007.10.009","article-title":"Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets","volume":"84","author":"Wright","year":"2008","journal-title":"Prog. Neurobiol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913001751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913001751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:02:19Z","timestamp":1762142539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913001751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":42,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0014299913001751"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.02.054","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combined treatment with gabapentin and drugs affecting the renin\u2013angiotensin system against electroconvulsions in mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.02.054","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}